• AERA Health

  Participated · Seed · Mar 2023

  AERA Health offers a hybrid model that brings data-driven P4 medicine to consumers via existing healthcare infrastructure. Its platform integrates personalised health data, counsel from medical professionals, and technology to enable predictive, preventive, personalised, and participatory care. The company will use the recent funding to roll out its platform and hire new team members. AERA will initially serve customers in the DACH region and is opening its first physical treatment space in Munich in April. It plans additional physical spaces offering health checks, ortho-biologics, and longevity medicine services throughout 2023. The round reportedly places the company at a valuation in the “mid 20's” region.

No current team members are available.